Enabling Digital Biomarkers Through a Regulated Platform

Time: 5:15 pm
day: Track A - Day 1 pm


  • How new digital biomarkers and endpoints may deliver previously unharnessed insights
  • How deploying a regulated platform approach can integrate sources of biomarker data to develop validated solutions
  • Best practices on how one may leverage clinical relevant data to adhere to regulatory obligations
  • How to employ the mechanism and framework necessary to align stakeholder input